Application of statistics in Pharmaceutical industry * * * Bookmark Although the advancement of medicine has prolonged and improved the life of many people over the years‚ it is important to remember that it is not an exact science. While some treatments do seem to offer a complete ’cure’ for any particular ailment universally‚ the vast majority of medicinal treatments do not. As such‚ it is important that statistics are used in medicine in order to justify the development and subsequent
Premium Obesity Metabolic syndrome
Mindy’s Sections Profitability BJB intends to apply a six sigma approach to improving profitability in the innovative CD changers. Using such tools provided through this approach will lead to major cost reduction and quality improvements that will result in an increase in profitability. The approach will involve measuring capability of processes to produce services and products that remain free of defect. Experts at BJB will analyze standard deviation‚ short term performance data‚ and critical
Premium United States Environmental Protection Agency Six Sigma Air pollution
Institutional Area‚ Behind the Grand Hotel‚ Vasant Kunj‚ New Delhi – 110070 Tel.: 2612409090 / 91; Fax: 26124092 E-mail: administration@srisim.org; Website: www.srisim.org DEVELOPMENT DAY PROJECT REPORT STRATEGIC ALLIANCE IN INDIAN PHARMACEUTICAL INDUSTRY Submitted by: | Name: Jagriti Singh (20090123) Amardeep Tomar(20090106) Shilpa Jaiswal(20090155) Anil Chauhan(20090108) | Batch: | 2009 – 2011. | MANAGING THROUGH WISDOM INTRODUCTION The
Premium Pharmaceutical industry Pharmacology Drug discovery
Motivating high performance in pharmaceutical sales teams is a growing issue in the pharmaceutical industry. The challenges facing the pharmaceutical industry in motivating sales teams are compounded by a variety of factors that many other industries do not face including: government regulation of sales practices‚ non-direct tracking of sales results‚ and the impact of managed care on sales performance. By impacting a few key team process and compensation elements pharmaceutical companies can have a significant
Premium Pharmacology Pharmaceutical drug Pharmacy
TRAPHACO JOIN STOCK COMPANY (TRA) DOMESCO MEDICAL IMPORT-EXPORT JOIN STOCK COMPANY (DMC) HAUGIANG PHARMACEUTICAL JOIN STOCK COMPANY (DHG) IMEXPHARM PHARMACEUTICAL JOIN STOCK COMPANY (IMP) gROUP PHARMACEUTICAL: truong quang khoa huynh minh tri Cao huynh ngoc khanh huynh le phuong thao ngo thi ngoc anh to ha cat anh Contents 1 INTRODUCTION 1.1 INDUSTRIAL OVERVIEW Pharmaceutical industry is an important sector in the national economy‚ the production of functional medicine service
Premium Generally Accepted Accounting Principles Asset Balance sheet
Factor : Size of droplets Other than emulsion stability and viscosity ‚ the droplet size of the oil also do influence in the formulation of the Parenteral nutrition emulsions. This can be seen in the creaming of an emulsion. The creaming of an emulsion is best explained by the Stokes’ equation: Where ( ) is the rate of creaming ‚ r is average radius of the droplet‚ (po-pw) is the different density between oil phase and water phase‚ g is the gravity and n is refer to the viscosity of the emulsion
Premium Liquid
According to the first class‚ the power point showed that the pharmaceutical industry is the most profitable industry. Based on the Porter’s five forces model‚ there are convincing explanation why the pharmaceutical industry has big profitability. For the threat of new entrants perspective‚ it is high. The pharmaceutical industry has a big barrier to prevent newcomers to enter this industry such as R&D costs‚ patents limitation‚ the long length of clinical time‚ the percentage of FDA to approve drug
Premium Pharmaceutical industry Pharmacology Mergers and acquisitions
Bangladesh pharmaceutical market in 2011 stood at approximately US $ 800 million‚ which is very small when compared to the population base of the country‚ which currently stands at about 140 million. To put this number on a proper perspective‚ the total global pharmaceutical sale in 2011 was $600 billion. This is expected to grow about $730 billion in 2013. Of course the majority of the sale in 2011 was in brand products‚ the market segment where Bangladesh does not or is not expected to participate
Premium Inflation Central Intelligence Agency Economic growth
The global pharmaceutical industry – in the land of shrinking giants. 1. Introduction The case describes the evolution of the industry and its unusual strategic environment. Attention is drawn to environmental pressures from regulators and payers. Key forces driving the industry are discussed‚ including addressing unmet medical need‚ the importance of innovation and time to market‚ and globalisation. The case illustrates how an increasingly hostile environment‚ combined with a decline in R&D
Premium Strategic management Industry Management
forces affecting the global pharmaceutical industry? Do these forces differ by industry sector‚ and where would you place the different sectors in the industry life-cycle? Porter’s five forces help identify their attractiveness in the industry in terms of the five competitive forces which are: the threat to entry‚ the threat of substitutes‚ the power of buyers‚ the power of suppliers and the extent of rivalry between the competitors. Where the forces are high‚ industries are not attractive to compete
Premium Barriers to entry Porter five forces analysis Pharmaceutical industry